Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

Neurulation

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cell Cycle Sensing Shapes Human T Cell Fate and Exhaustion Programs.

bioRxiv : the preprint server for biology·2026

Same author

Cell-autonomous control of CAR signaling and receptor shedding via ADAM17-mediated proteolysis.

Cell·2026

Same author

Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.

Blood cancer journal·2026

Same author

Predictive biomarkers of response to chimeric antigen receptor (CAR) T-cell therapy for pan-haematologic cancer.

Nature biomedical engineering·2026

Same author

c-JUN enhances CRISPR knockin anti-B7-H3 CAR T cell function in small cell lung cancer and thoracic SMARCA4-deficient undifferentiated tumors.

Cell reports. Medicine·2026

Same author

Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

Blood cancer discovery·2025

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Accidental hypothermia.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Primary aldosteronism.

Nature reviews. Disease primers·2026

Same journal

Buruli ulcer in Africa: between innovation and pragmatism.

Nature reviews. Disease primers·2026

Same journal

Author Correction: Atopic dermatitis.

Nature reviews. Disease primers·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 12, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

Neuroblastoma.

Katherine K Matthay^1,2, John M Maris^3,4, Gudrun Schleiermacher⁵

¹Department of Pediatrics and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California 94158, USA.

Nature Reviews. Disease Primers

|November 11, 2016

Summary

This summary is machine-generated.

Neuroblastoma, a common childhood cancer, presents unique challenges due to its metastatic potential and MYCN oncogene amplification. Advances in risk-stratified therapy and targeted treatments are improving survival rates for affected children.

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Zebrafish Model of Neuroblastoma Metastasis

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Related Experiment Videos

Last Updated: Mar 12, 2026

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

An Orthotopic Sciatic Nerve Xenograft for Neurofibromatosis Type 1 Neurofibromas

Published on: October 10, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

Zebrafish Model of Neuroblastoma Metastasis

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Area of Science:

Pediatric Oncology
Cancer Genetics
Tumor Biology

Background:

Neuroblastoma is the most common childhood extracranial solid tumor.
It exhibits diverse clinical behaviors influenced by tumor biology, including early onset, frequent metastasis, and spontaneous regression.
Malignant forms often feature MYCN oncogene amplification, correlating with poor prognosis.

Purpose of the Study:

To review the diverse clinical presentation and biological factors influencing neuroblastoma.
To discuss genetic alterations, including MYCN amplification and ALK mutations, and their prognostic significance.
To summarize current risk-stratified therapeutic approaches and emerging treatment strategies.

Main Methods:

Review of existing literature on neuroblastoma biology, genetics, and treatment.
Analysis of factors influencing tumor behavior and patient outcomes.
Synthesis of current therapeutic advancements and future directions.

Main Results:

MYCN amplification is a key indicator of aggressive disease and poor survival.
Segmental chromosome alterations are frequent and associated with worse outcomes.
Risk-stratified therapy has improved outcomes for low- and intermediate-risk patients.
Intensive chemotherapy, differentiation therapy, and immunotherapy have increased 5-year survival to 50% for high-risk patients.

Conclusions:

Neuroblastoma management requires understanding its complex biology and genetic landscape.
Risk-stratified therapy and novel targeted treatments are crucial for improving patient survival and quality of life.
Ongoing research into genetic pathways and the tumor microenvironment holds promise for future therapeutic breakthroughs.